These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8530951)
1. Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy. Bandmann O; Wenning GK; Quinn NP; Harding AE J Neurol Neurosurg Psychiatry; 1995 Nov; 59(5):557. PubMed ID: 8530951 [No Abstract] [Full Text] [Related]
2. DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisers. Panserat S; Mura C; Gérard N; Vincent-Viry M; Galteau MM; Jacqz-Aigrain E; Krishnamoorthy R Hum Genet; 1994 Oct; 94(4):401-6. PubMed ID: 7927337 [TBL] [Abstract][Full Text] [Related]
3. A polymorphic CfoI site in exon 6 of the human cytochrome P450 CYP2D6 gene detected by the polymerase chain reaction. Armstrong M; Idle JR; Daly AK Hum Genet; 1993 Jul; 91(6):616-7. PubMed ID: 8340116 [TBL] [Abstract][Full Text] [Related]
7. Familial Parkinson's disease and polymorphism at the CYP2D6 locus. Mazzetti P; Le Guern E; Bonnet AM; Vidailhet M; Brice A; Agid Y J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):871-2. PubMed ID: 8021689 [No Abstract] [Full Text] [Related]
8. [Genetic polymorphism of drug metabolizing enzymes]. Yokoi T; Kamataki T Seikagaku; 1997 Oct; 69(10):1196-9. PubMed ID: 9431010 [No Abstract] [Full Text] [Related]
9. Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism. Landi MT; Ceroni M; Martignoni E; Bertazzi PA; Caporaso NE; Nappi G Adv Neurol; 1996; 69():61-72. PubMed ID: 8615186 [No Abstract] [Full Text] [Related]
10. "It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism. Kroemer HK; Eichelbaum M Life Sci; 1995; 56(26):2285-98. PubMed ID: 7791516 [TBL] [Abstract][Full Text] [Related]
11. Lack association between schizophrenia and the CYP2D6 gene polymorphisms. Pirmohamed M; Wild MJ; Kitteringham NR; O'Brien K; Buchan IE; Back DJ; Park BK Am J Med Genet; 1996 Apr; 67(2):236-7. PubMed ID: 8723057 [No Abstract] [Full Text] [Related]
12. Cloning and sequencing of a new non-functional CYP2D6 allele: deletion of T1795 in exon 3 generates a premature stop codon. Evert B; Griese EU; Eichelbaum M Pharmacogenetics; 1994 Oct; 4(5):271-4. PubMed ID: 7894499 [No Abstract] [Full Text] [Related]
18. Pharmacogenetics: Part II. Gibaldi M Ann Pharmacother; 1992 Feb; 26(2):255-61. PubMed ID: 1554942 [No Abstract] [Full Text] [Related]
19. Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene. Broly F; Meyer UA Pharmacogenetics; 1993 Jun; 3(3):123-30. PubMed ID: 8101460 [TBL] [Abstract][Full Text] [Related]
20. A nonsense mutation in the cytochrome P450 CYP2D6 gene identified in a Caucasian with an enzyme deficiency. Broly F; Marez D; Lo Guidice JM; Sabbagh N; Legrand M; Boone P; Meyer UA Hum Genet; 1995 Nov; 96(5):601-3. PubMed ID: 8530011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]